Collaborate with Us h1 >
Our shared research infrastructure supports collection and analysis of robust clinical data and biological specimen to pave the way for transformative therapeutic trials across the leukodystrophies.
Who are we?
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is a consortium of scientists, industry stakeholders, and patient advocacy leaders working together to promote advances in the diagnosis and treatment of leukodystrophies.
The Global Leukodystrophy Initiative Clinical Trials Network is the culmination of over a decade of collaborative research efforts and partnership with advocacy organizations worldwide. These stakeholders are united in their efforts to bring increased awareness to the leukodystrophy community as they continue pursuing new clinical and scientific advances.